NUP133 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.70269999999873E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.04430000039224E-07 |
Normal-vs-Stage2 |
1.256680E-03 |
Normal-vs-Stage3 |
8.064100E-02 |
Normal-vs-Stage4 |
1.774260E-02 |
Stage1-vs-Stage2 |
9.739200E-01 |
Stage1-vs-Stage3 |
2.054400E-01 |
Stage1-vs-Stage4 |
7.145400E-01 |
Stage2-vs-Stage3 |
3.691200E-01 |
Stage2-vs-Stage4 |
6.896800E-01 |
Stage3-vs-Stage4 |
3.259400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.03539999998892E-06 |
Normal-vs-AfricanAmerican |
2.24919999999296E-05 |
Normal-vs-Asian |
1.817840E-03 |
Caucasian-vs-AfricanAmerican |
6.442600E-01 |
Caucasian-vs-Asian |
5.335000E-01 |
AfricanAmerican-vs-Asian |
5.948800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.68190003538393E-09 |
Normal-vs-Female |
3.662400E-01 |
Male-vs-Female |
1.209940E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.896480E-03 |
Normal-vs-Extreme_Weight |
1.29430000050945E-08 |
Normal-vs-Obese |
3.418700E-03 |
Normal-vs-Extreme_Obese |
1.571770E-02 |
Normal_Weight-vs-Extreme_Weight |
1.392980E-01 |
Normal_Weight-vs-Obese |
6.090200E-01 |
Normal_Weight-vs-Extreme_Obese |
4.643200E-01 |
Extreme_Weight-vs-Obese |
2.478000E-02 |
Extreme_Weight-vs-Extreme_Obese |
9.487200E-01 |
Obese-vs-Extreme_Obese |
2.905200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.677200E-01 |
Normal-vs-Age(41-60Yrs) |
2.231400E-04 |
Normal-vs-Age(61-80Yrs) |
2.04340000031777E-07 |
Normal-vs-Age(81-100Yrs) |
1.84420000004515E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.078400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.765620E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.510300E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.756850E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.168100E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.379600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.94440000159213E-08 |
Normal-VS-Type2 PRCC |
4.834100E-04 |
Normal-VS-KIRP CIMP |
4.123600E-01 |
Normal-VS-Unclassified PRCC |
5.943900E-02 |
Type1 PRCC-VS-Type2 PRCC |
2.972000E-01 |
Type1 PRCC-VS-KIRP CIMP |
2.640400E-01 |
Type1 PRCC-VS-Unclassified PRCC |
7.562400E-02 |
Type2 PRCC-VS-KIRP CIMP |
5.832800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
4.289400E-01 |
KIRP CIMP-VS-Unclassified PRCC |
9.459600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.5687000032294E-08 |
Normal-vs-N1 |
8.917600E-01 |
Normal-vs-N2 |
4.876000E-01 |
N0-vs-N1 |
1.064180E-02 |
N0-vs-N2 |
2.851800E-01 |
N1-vs-N2 |
6.063400E-01 |
|
|